BACKGROUND: The primary purpose of this investigation was to assess the neural correlates of implicit cueing during an inhibitory task in schizophrenia when performance accuracy was matched with healthy comparison subjects. METHODS: We compared 17 individuals with chronic schizophrenia (SZ; medicated, 13.9 average years of illness) and 17 healthy comparison subjects (HC) matched for hit and false alarm rates, age, and education on a visual Go/Nogo task during functional magnetic resonance imaging. In this task, one of the go stimuli also served implicitly as a cue predictive of a subsequent inhibitory (Nogo) trial. CONCLUSIONS: Findings suggest that even when matched for overall performance accuracy, individuals with SZ exhibit difficulties with inhibition and cue processing that may relate to core deficits in cognitive control and stimulus processing. In particular, these findings point towards an important role of the parietal cortex for cued inhibitory processes in healthy populations.
BACKGROUND: The primary purpose of this investigation was to assess the neural correlates of implicit cueing during an inhibitory task in schizophrenia when performance accuracy was matched with healthy comparison subjects. METHODS: We compared 17 individuals with chronic schizophrenia (SZ; medicated, 13.9 average years of illness) and 17 healthy comparison subjects (HC) matched for hit and false alarm rates, age, and education on a visual Go/Nogo task during functional magnetic resonance imaging. In this task, one of the go stimuli also served implicitly as a cue predictive of a subsequent inhibitory (Nogo) trial. CONCLUSIONS: Findings suggest that even when matched for overall performance accuracy, individuals with SZ exhibit difficulties with inhibition and cue processing that may relate to core deficits in cognitive control and stimulus processing. In particular, these findings point towards an important role of the parietal cortex for cued inhibitory processes in healthy populations.
Authors: Qing Zhao; Zhi Li; Jia Huang; Chao Yan; Paola Dazzan; Christos Pantelis; Eric F C Cheung; Simon S Y Lui; Raymond C K Chan Journal: Schizophr Bull Date: 2013-05-13 Impact factor: 9.306
Authors: Fabio Sambataro; Venkata S Mattay; Kristina Thurin; Martin Safrin; Roberta Rasetti; Giuseppe Blasi; Joseph H Callicott; Daniel R Weinberger Journal: Neuropsychopharmacology Date: 2012-12-05 Impact factor: 7.853
Authors: Andrew R Mayer; David Ruhl; Flannery Merideth; Josef Ling; Faith M Hanlon; Juan Bustillo; Jose Cañive Journal: Hum Brain Mapp Date: 2012-03-28 Impact factor: 5.038
Authors: Jessica W O'Brien; Andria L Norman; Susanna L Fryer; Susan F Tapert; Martin P Paulus; Kenneth Lyons Jones; Edward P Riley; Sarah N Mattson Journal: Alcohol Clin Exp Res Date: 2012-10-24 Impact factor: 3.455
Authors: Susanna L Fryer; Brian J Roach; Judith M Ford; Kayla R Donaldson; Vince D Calhoun; Godfrey D Pearlson; Kent A Kiehl; Vinod H Srihari; Thomas H McGlashan; Scott W Woods; Daniel H Mathalon Journal: Schizophr Bull Date: 2019-01-01 Impact factor: 9.306
Authors: Benedicte Ballanger; Thilo van Eimeren; Elena Moro; Andres M Lozano; Clement Hamani; Philippe Boulinguez; Giovanna Pellecchia; Sylvain Houle; Yu Yan Poon; Anthony E Lang; Antonio P Strafella Journal: Ann Neurol Date: 2009-12 Impact factor: 10.422
Authors: Andrew R Mayer; Faith M Hanlon; Terri M Teshiba; Stefan D Klimaj; Josef M Ling; Andrew B Dodd; Vince D Calhoun; Juan R Bustillo; Trent Toulouse Journal: Br J Psychiatry Date: 2015-09-17 Impact factor: 9.319